Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zika: WHO evaluates mosquito controls
aedes mosquito
Zika outbreaks are thought to be linked to serious birth defects and a rise in cases of
Guillain-Barré syndrome.
Release of sterile mosquitoes among possibilities 

The World Health Organisation (WHO) is evaluating a suite of new methods to control mosquito populations in a bid to tackle Zika virus, which is primarily spread by the Aedes aegypti mosquito.

Current possibilities include the introduction of genetically modified mosquitoes, or sterile male insects to suppress the population.

Zika was recently declared a global health emergency as it spread across the Americas. The outbreaks are thought to be linked to serious birth defects and a rise in cases of the autoimmune disorder, Guillain-Barré syndrome, though this has not yet been scientifically proven.

While 15 groups are currently working to develop a vaccine, WHO predicts it could take at least 18 months before large-scale trials can take place. With this in mind, the organisation is recommending better mosquito control as the best line of defence.

WHO has convened a vector control advisory group to consider new tools, including GM mosquitoes, which have previously been trialled in the Cayman Islands resulting in a significant decline in mosquito populations.

The group is backing further field trials and risk assessment to look into the potential impact on disease transmission.

Another strategy being developed is the release of sterile male insects so that when females mate with them, their eggs are not viable and the insect population dies out.

The release of males carrying the naturally occurring Wolbachia bacteria is another option. The bacteria does not affect humans or other mammals but prevents mosquito eggs hatching when females mate with affected males.

A different strain reduces the insect's capacity to spread dengue virus. Mosquitoes carrying the bacteria have already been released in a number of places, including Australia, Brazil, Indonesia and Vietnam as part of dengue control programmes. Large-scale field trials are expected to begin soon.

Meanwhile, WHO advocates the elimination of mosquito breeding sites as an effective intervention, as well as the use of insect repellents.

For more of the WHO's guidance, see: http://www.who.int/emergencies/zika-virus/articles/mosquito-control/en/

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
New guidance for antibiotic use in rabbits

New best practice guidance on the responsible use of antibiotics in rabbits has been published by the BSAVA in collaboration with the Rabbit Welfare Association & Fund (RWA&F).

The guidance is free and has been produced to help veterinary practitioners select the most appropriate antibiotic for rabbits. It covers active substance, dose and route of administration all of which are crucial factors when treating rabbits owing to the risk of enterotoxaemia.

For more information and to access the guide, visit the BSAVALibrary.